Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective Cohort
- PMID: 28863009
- PMCID: PMC5679071
- DOI: 10.1097/ADM.0000000000000353
Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective Cohort
Abstract
Objective: Methadone is associated with prolongation of the electrocardiographic QTc interval. QTc prolongation may be linked to cardiac dysrhythmia and sudden cardiac death. The rate of these events is unknown in methadone-maintained patients.
Methods: This retrospective cohort study of 749 patients with opioid use disorder receiving methadone maintenance therapy through a single safety-net hospital, queried the electronic health record for electrocardiogram results, demographics, methadone dose, and diagnostic codes consistent with cardiac conduction disorder (International Classification of Disease, Ninth Revision [ICD-9] 426) and cardiac dysrhythmia (ICD-9 427). Factors associated with QTc interval were explored; Cox proportional-hazards regression models were used to analyze time to an event that may predispose to sudden cardiac death.
Results: One hundred thirty-four patients had an electrocardiogram while on methadone, 404 while off methadone, and 211 both while on and off methadone. Mean QTc interval while on methadone (436 ms, SD 36) was significantly greater than while off methadone (423 ms, SD 33). Age and methadone dose were weakly associated with increased QTc interval (P < 0.01 and P < 0.0005, respectively, adjusted R = 0.05). There were 44 ICD-9 426 and 427 events over 7064 patient-years (6.3 events/1000 patient-yrs). Having a QTc greater than sex-specific cut-off values was significantly associated with time to event (hazard ratio 3.32, 95% confidence interval 1.25-8.81), but being on methadone was not.
Conclusions: Methadone is associated with QTc prolongation in a nonclinically significant dose-related manner. Cardiac events were rare and the sudden cardiac death rate was below that of the general population. Current recommendations for cardiac risk assessment in methadone-maintained patients should be reconsidered.
Figures
Comment in
-
Regarding Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective Cohort, Gavin Bart et al.J Addict Med. 2018 Mar/Apr;12(2):167. doi: 10.1097/ADM.0000000000000382. J Addict Med. 2018. PMID: 29528915 No abstract available.
-
Author Response to Stoklosa and Haber.J Addict Med. 2018 Mar/Apr;12(2):167-168. doi: 10.1097/ADM.0000000000000383. J Addict Med. 2018. PMID: 29528916 No abstract available.
Similar articles
-
Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.Addiction. 2012 Jun;107(6):1132-9. doi: 10.1111/j.1360-0443.2011.03767.x. Epub 2012 Feb 28. Addiction. 2012. PMID: 22168435
-
Methadone maintenance dose/weight ratio, long QTc, and EKG screening.Am J Addict. 2016 Sep;25(6):499-507. doi: 10.1111/ajad.12423. Epub 2016 Aug 22. Am J Addict. 2016. PMID: 27548638
-
Onsite QTc interval screening for patients in methadone maintenance treatment.J Addict Dis. 2010 Jan;29(1):15-22. doi: 10.1080/10550880903436044. J Addict Dis. 2010. PMID: 20390695
-
[Review of cases of prolonged QTC and wave burst arrhythmia in patients treated with methadone].Encephale. 2012 Feb;38(1):58-63. doi: 10.1016/j.encep.2011.02.005. Epub 2011 May 25. Encephale. 2012. PMID: 22381725 Review. French.
-
QTc interval screening in methadone treatment.Ann Intern Med. 2009 Mar 17;150(6):387-95. doi: 10.7326/0003-4819-150-6-200903170-00103. Epub 2009 Jan 19. Ann Intern Med. 2009. PMID: 19153406
Cited by
-
Effects of hydroxychloroquine treatment on QT interval.Heart Rhythm. 2020 Nov;17(11):1930-1935. doi: 10.1016/j.hrthm.2020.06.029. Epub 2020 Jun 28. Heart Rhythm. 2020. PMID: 32610165 Free PMC article.
-
Effectiveness of opioid maintenance programs for treating drug dependence in prisons.Rev Esp Sanid Penit. 2023 Sep-Dec;25(3):112-121. doi: 10.18176/resp.00077. Rev Esp Sanid Penit. 2023. PMID: 38289166 Free PMC article. Review.
-
Applying the Infectious Diseases Literature to People who Inject Drugs.Infect Dis Clin North Am. 2020 Sep;34(3):539-558. doi: 10.1016/j.idc.2020.06.010. Infect Dis Clin North Am. 2020. PMID: 32782101 Free PMC article. Review.
-
Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.Arch Toxicol. 2020 Aug;94(8):2809-2827. doi: 10.1007/s00204-020-02766-7. Epub 2020 May 4. Arch Toxicol. 2020. PMID: 32367273 Free PMC article.
-
Things We Do for No Reason™: Avoiding methadone for opioid withdrawal.J Hosp Med. 2023 Nov;18(11):1034-1037. doi: 10.1002/jhm.13138. Epub 2023 May 27. J Hosp Med. 2023. PMID: 37244869 Free PMC article. No abstract available.
References
-
- Anchersen K, Clausen T, Gossop M, et al. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction. 2009;104:993–99. - PubMed
-
- Butler B, Rubin G, Lawrance A, et al. Estimating the risk of fatal arrhythmia in patients in methadone maintenance treatment for heroin addiction. Drug Alcohol Rev. 2011;30:173–80. - PubMed
-
- Center for Behavioral Health Statistics and Quality. Substance Abuse and Mental Health Services Administration. Rockville, MD: Department of Health and Human Services; 2016. 2015 National Survey on Drug Use and Health: Detailed Tables.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources